Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
---|
10/26/2010 | US7820619 potentiate antimicrobial functions of leukocytes such as neutrophils; lower inherent mammalian cell toxicities, improved immunogenicity and shortness of duration of effectiveness due to biodegradation, retaining activity in plasma and serum; antibiotic resistance; pharmacokinetics |
10/26/2010 | US7820400 Tumor-associated marker |
10/26/2010 | US7820390 Methods of and kits and compositions for diagnosing colorectal tumors |
10/26/2010 | CA2133323C Self-assembling polynucleotide delivery system |
10/21/2010 | WO2010121023A2 Peptides and aptamers for targeting of neuron or nerves |
10/21/2010 | WO2010121013A2 Molecularly imprinted polymers for detecting hiv-1 |
10/21/2010 | WO2010119583A1 Polymer-nucleic acid complex, method for imaging tumor cells or the like using same, and pharmaceutical composition for treatment of cancer |
10/21/2010 | WO2010119192A1 Cosmetic and/or pharmaceutical composition comprising a relieving peptidic hydrolysate |
10/21/2010 | WO2010119191A1 Cosmetic and/or pharmaceutical composition comprising a peptidic hydrolysate that can reinforce the barrier function |
10/21/2010 | WO2010118547A1 Protein for the immunocastration for mammals |
10/21/2010 | WO2010118521A1 Peptide ligands for clusterin and uses thereof |
10/21/2010 | WO2010099472A3 Spanx-b polypeptides and their use |
10/21/2010 | WO2010065815A3 Mini-hepcidin peptides and methods of using thereof |
10/21/2010 | WO2009111273A3 Peptide targeting imaging agents and methods of use thereof |
10/21/2010 | US20100267928 Activatable diagnostic and therapeutic compound |
10/21/2010 | US20100267927 Structure of the Insulin Receptor Ectodomain |
10/21/2010 | US20100267651 T cell antigen receptor peptides |
10/21/2010 | US20100267650 Dual Chain Synthetic Heparin-Binding Growth Factor Analogs |
10/21/2010 | US20100267628 Analogs of Gastric Inhibitory Polypeptide and Their Use for Treatment of Diabetes |
10/21/2010 | US20100267623 Peptides with capacity to bind to scurfin and applications |
10/21/2010 | US20100267621 Antimicrobial Compounds and Formulations |
10/21/2010 | US20100267608 Modifications of cupredoxin derived peptides and methods of use thereof |
10/21/2010 | US20100267019 Identification And Use Of Genes Encoding Amatoxin And Phallotoxin |
10/21/2010 | US20100267005 Crosslinking Within Coordination Complexes |
10/21/2010 | US20100266686 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases |
10/21/2010 | US20100266598 Peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5 |
10/21/2010 | US20100266557 Novel peptide-based scaffolds for cartilage regeneration and methods for their use |
10/21/2010 | US20100266508 Stabilized gold nanoparticle and contrast agent |
10/21/2010 | CA2756570A1 Peptide ligands for clusterin and uses thereof |
10/21/2010 | CA2669470A1 Assay for detecting cathepsin k activity in bone, cartilage and/or soft tissue |
10/20/2010 | EP2241573A2 Peptide derivatives and cosmetic composition comprising the same |
10/20/2010 | EP2240770A1 Methods for detection of cyclosporin a |
10/20/2010 | EP2240604A2 Peptides and methods of use as therapeutics and screening agents |
10/20/2010 | EP2240507A2 Processes for preparing high purity aza cyclohexapeptides |
10/20/2010 | EP1866415B1 A cysteine-containing peptide tag for site-specific conjugation of proteins |
10/20/2010 | CN101863971A Metastin derivatives and use thereof |
10/20/2010 | CN101863965A Helicobacter pylori urease B antigenic epitope polypeptide and application thereof |
10/20/2010 | CN101863964A Helicobacter pylori urease B antigen epitope polypeptide and application thereof |
10/20/2010 | CN101863963A Helicobacter pylori antigen epitope polypeptide and application thereof |
10/20/2010 | CN101863962A Polypeptide for inhibiting enzyme digestion of beta secretase and application thereof |
10/20/2010 | CN101863961A Preparation method of octreotide |
10/20/2010 | CN101863960A Preparation method of cetrorelix |
10/20/2010 | CN101863958A Induction of the mitochondrial permeability transition |
10/20/2010 | CN101225106B Short peptide suppressing growth of cancer cell and uses thereof |
10/19/2010 | US7816490 Peptide for use in the treatment of immunological defects and allergies; capable of inhibiting protein-protein interaction between calcineurin and NFAT |
10/19/2010 | US7816489 Methods for making intermediates and oxytocin analogues |
10/19/2010 | US7816325 secondary binding site of dipeptidyl peptidase IV, its relationship amongst substrates and to the modulation of substrate specificity of dipeptidyl peptidase IV (DP IV, synonym: DPP IV, CD26, EC 3.4.14.5). The application relates further to compounds that bind to the secondary binding site of DP IV |
10/19/2010 | CA2437081C Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
10/19/2010 | CA2334914C Methods for determining presence of cancer in a sample by determining expression of an ssx gene, peptides derived from said ssx gene and ny-eso-1 gene, and uses thereof |
10/19/2010 | CA2193130C New streptogramins and process for preparing streptogramins by mutasynthesis |
10/19/2010 | CA2147499C Prostate-specific membrane antigen |
10/14/2010 | WO2010117997A2 Peptide targeting of inner ear cells |
10/14/2010 | WO2010117753A2 Peptide compositions for oral care systems |
10/14/2010 | WO2010117079A1 Neuronal differentiation-inducing peptide and use thereof |
10/14/2010 | WO2010117078A1 Neuronal differentiation-inducing peptide and use thereof |
10/14/2010 | WO2010117055A1 Polypeptide having selective inhibitory activity on protein kinase cα or η |
10/14/2010 | WO2010116752A1 Neuromedin u derivative |
10/14/2010 | WO2010115916A1 Process for isolating therapeutic peptide |
10/14/2010 | WO2010074433A3 Novel bacteriophage and antibacterial composition comprising same |
10/14/2010 | WO2010042548A9 Methods of treating inflammation |
10/14/2010 | US20100261877 Process for isolating therapeutic peptides |
10/14/2010 | US20100261876 Novel methods of synthesis for therapeutic antiviral peptides |
10/14/2010 | US20100261875 Peptides that specifically bind HGF receptor (CMET) and uses thereof |
10/14/2010 | US20100261658 Peptide for activating aquaporin synthesis |
10/14/2010 | US20100261650 Recombinant fusion proteins to growth hormone and serum albumin |
10/14/2010 | US20100261638 Lantibiotic-based compounds having antimicrobial activity |
10/14/2010 | US20100261273 Mammalian Receptor Proteins; Related Reagents and Methods |
10/14/2010 | US20100261206 Peptide fragments reacting specifically with antibodies against highly pathogenic newcastle disease virus and uses thereof |
10/14/2010 | US20100260817 Polyamine Derivatives |
10/14/2010 | US20100260791 Chlamydia antigens |
10/14/2010 | US20100260790 S. Pneumoniae Antigens |
10/14/2010 | US20100260752 Opsonic and protective antibodies specific for lipoteichoic acid of gram positive bacteria |
10/14/2010 | US20100260673 Phage display peptide probes for imaging early responses to antiangiogenic treatment |
10/14/2010 | US20100260672 Peptides that specifically bind hgf receptor (cmet) and uses thereof |
10/14/2010 | CA2758264A1 Neuromedin u derivative |
10/13/2010 | EP2239270A2 Low molecular weight peptide derivatives as inhibitors of the Laminin/Nidogen interaction |
10/13/2010 | EP2239267A1 Tag peptide and use thereof |
10/13/2010 | CN101861334A Cyclic receptor-associated protein (RAP) peptides |
10/13/2010 | CN101861330A Polypeptide compound |
10/13/2010 | CN101861329A Peptides as antimicrobial agents towards campylobacter spp |
10/13/2010 | CN101861160A Antagonists of kisspeptin and uses thereof |
10/13/2010 | CN101857632A Preparation and use of fatty acyl glycyl glycyl histidine-copper (II) complexes |
10/13/2010 | CN101857631A Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
10/13/2010 | CN101857630A Fluorouracil derivative containing tyrosine-isoleucine-glycine-serine-arginine polypeptide |
10/13/2010 | CN101857629A Solid-phase synthesis method of Bremelanotide |
10/13/2010 | CN101190939B Oligopeptide-copper complex with blood vessel extending and thrombus dissolving activity and its preparation method and application |
10/12/2010 | US7812118 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD) |
10/12/2010 | US7811995 Therapeutic and diagnostic peptides |
10/12/2010 | US7811993 BRAFV600E-based peptide mutants that induce major histocompatibility complex (MHC) Class I-dependent cytotoxic T cell responses provide prophylactic, diagnosis and therapeutic treatments; anticarcinogenic agents; drug development for non-peptide mimetics and in development of antibodies, vaccines |
10/12/2010 | US7811992 Measuring binding of Bradykinin and angiogensin receptor; calibration; animal hibernation |
10/12/2010 | US7811985 Treatment and prophylaxis of reperfusion injuries, particularly after cardiac necrosis; administering an N-terminus modified polypeptide derived from the A alpha chain of fibrinand the B beta chain of fibrin; antiinflammatory agents |
10/12/2010 | US7811828 Method for identifying and quantifying of tumuor-associated |
10/12/2010 | US7811551 Peptide-based compounds for use as targeting vectors that bind to receptors associated with angiogenesis; may thus be used for diagnosis or therapy of, for example, malignant diseases, heart diseases, endometriosis, inflammation-related diseases, rheumatoid arthritis and Kaposi's s sarcoma |
10/12/2010 | CA2497287C Method of humanizing immune system molecules |
10/07/2010 | WO2010115080A2 Self-assembling peptides bearing organic electronic functionality and applications employing the same |
10/07/2010 | WO2010115052A2 Induced pluripotent stem cells |
10/07/2010 | WO2010114185A1 Method for preparing dendritic cells with capacity to induce cancer-specific immune response, and pharmaceutical composition and kit incorporating dendritic cells for preventing or treating cancer or inhibiting metastasis |
10/07/2010 | WO2010113753A1 Prophylactic or therapeutic agent for retinal diseases and method for preventing or treating retinal diseases, each comprising jnk (c-jun n-terminal kinase)-inhibiting peptide, and use of the peptide |
10/07/2010 | WO2010113495A1 C6orf167 peptides and vaccines containing the same |
10/07/2010 | WO2010113042A1 Antimicrobial cyclic peptides |